0480-9242
Generic: propylthiouracil
Labeler: teva pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
Generic Name
propylthiouracil
Labeler
teva pharmaceuticals, inc.
Dosage Form
TABLET
Active Ingredients
propylthiouracil 50 mg/1
Identifiers & Regulatory
Product NDC
0480-9242
Product ID
0480-9242_2f1571a0-a7c1-4218-9330-a8cc3af347e0
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2023-10-27
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04809242
Hyphenated Format
0480-9242
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
propylthiouracil (source: label)
Generic Name
propylthiouracil (source: ndc)
Application Number
ANDA080172 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 50 mg/1
Packaging
- 52630 TABLET in 1 BOX (0480-9242-00)
- 63156 TABLET in 1 CONTAINER (0480-9242-77)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "2f1571a0-a7c1-4218-9330-a8cc3af347e0", "openfda": {}, "finished": false, "packaging": [{"description": "52630 TABLET in 1 BOX (0480-9242-00)", "package_ndc": "0480-9242-00", "marketing_start_date": "27-OCT-23"}, {"description": "63156 TABLET in 1 CONTAINER (0480-9242-77)", "package_ndc": "0480-9242-77", "marketing_start_date": "22-APR-24"}], "product_id": "0480-9242_2f1571a0-a7c1-4218-9330-a8cc3af347e0", "dosage_form": "TABLET", "product_ndc": "0480-9242", "generic_name": "Propylthiouracil", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "PROPYLTHIOURACIL", "strength": "50 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20231027", "listing_expiration_date": "20261231"}